Furthermore, HCC patients with high TMEM100 expressions had much longer overall survival time (median survival time, 59.5 vs. 26.8 months, p = 0.030) than those with low TMEM100 expressions (Figure 5E). The gene discussed is TMEM100; the disease is hepatocellular carcinoma.